retatrutide trial update october 2025 Investigational weight-loss drug shows average reduced body weight of 30% 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁: 𝗪𝗵𝗮𝘁

Rational combinations with orthogonal metabolic agents can be explored, with careful endpoint alignment and safety monitoring

27 Other side effects and risks of GLP-1s include: Dizziness Mild tachycardia (increased heart rate) Headaches Injection site reactions, such as itchiness and redness Hypoglycemia (low blood sugar) Severe Risks & Contraindications While less common, GLP-1s can pose severe risks such as intestinal blockage and gastroparesis 28 , which refer to the delay in gastric emptying without evidence of mechanical obstruction

06.17.25 21 plaintiffs asked for consolidation in case against Novo Nordisk A group of New Jersey plaintiffs asked the state court to consolidate their cases into a multicounty litigation

Jastreboff AM et al., SURMOUNT-1, NEJM 2022 (NEJMoa2206038) : tirzepatide up to 15 mg, loss -22,5% at 72 weeks

Estrogen fluctuations differ markedly between species